Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2012
11/07/2012CN102021151B Method and kit for extracting superoxide dismutase
11/07/2012CN102010857B Method for producing acid xylanase from whey powder
11/07/2012CN101851633B Phage nuclease, and preparation and application thereof
11/07/2012CN101717761B Application of lumbrukinase in treating carotid atherosclerosis
11/07/2012CN101553503B SHRNA-mediated inhibition of expression of alpha-1,6-fucosyltransferase
11/07/2012CN101535472B Grain incomplete filling gene (GIF1) and uses thereof
11/07/2012CN101525605B Araboxylan degrading enzyme
11/07/2012CN101497878B Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use
11/07/2012CN101392224B Aspergillus niger strain for high yield of chlorogenic acid hydrolase and use thereof
11/07/2012CN101275128B Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region
11/07/2012CN101203534B Residual formamide in enzymatic decomposition polymers
11/07/2012CN101151364B Gene sms 14
11/07/2012CN101076587B Inositol polyphosphate 2-kinase genes and uses thereof
11/07/2012CN101040047B DNA encoding novel enzyme having D-serine synthase activity, method of producing the enzyme and method of producing d-serine by using the same
11/06/2012USRE43795 Method of pre-treating sample for measuring saccharified amine and method of measuring saccharified amine
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304400 Compositions and methods for inhibiting tumor growth and metastasis
11/06/2012US8304381 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
11/06/2012US8304249 Fructosyl peptide oxidase
11/06/2012US8304224 Compositions and methods relating to proteins requiring gamma-carboxylation
11/06/2012US8304223 Isoforms of pig liver esterase
11/06/2012US8304222 Rationally-designed meganucleases with altered sequence specificity and heterodimer formation
11/06/2012US8304221 Regulatable growth of filamentous fungi
11/06/2012US8304220 Bone semi-permeable device
11/06/2012US8304218 Enzymatic peracid production using a cosolvent
11/06/2012US8304212 Methods and compositions for degradation of lignocellulosic material
11/06/2012CA2450257C Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi expression
11/06/2012CA2447789C Removal of plasminogen or plasmin from protein solutions
11/06/2012CA2419996C Enhanced in vitro synthesis of active proteins containing disulfide bonds
11/02/2012CA2775299A1 Thrombin isolated from blood and blood fractions
11/01/2012WO2012149491A2 Recombinant microorganisms for enhanced production of mevalonate, isoprene, and isoprenoids
11/01/2012WO2012149469A1 Production of mevalonate, isoprene, and isoprenoids using genes encoding polypeptides having thiolase, hmg-coa synthase and hmg-coa reductase enzymatic activities
11/01/2012WO2012149403A1 Cellobiohydrolase variants
11/01/2012WO2012149333A1 Detergent compositions containing bacillus sp. mannanase and methods of use thereof
11/01/2012WO2012149325A1 Detergent compositions containing geobacillus tepidamans mannanase and methods of use thereof
11/01/2012WO2012149317A1 Detergent compositions containing bacillus agaradhaerens mannanase and methods of use thereof
11/01/2012WO2012149288A1 Single ph process for starch liquefaction and saccharification for high-density glucose syrups
11/01/2012WO2012149192A1 Polypeptides having endoglucanase activity and polynucleotides encoding same
11/01/2012WO2012149047A1 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012WO2012149011A1 Enhanced transformation of recalcitrant monocots
11/01/2012WO2012148275A1 Glyphosate resistance enhancement
11/01/2012WO2012148253A1 Undecaprenyl pyrophosphate synthase from the plant hevea brasiliensis
11/01/2012WO2012148249A2 Lactic acid bacteria-derived glycoside hydrolase and uses thereof
11/01/2012WO2012148023A1 Method for the isolation and purification of anhydrogalactose
11/01/2012WO2012147798A1 Method for detecting neurological disease associated with cognitive dysfunction by measuring epha4 extracellular domain
11/01/2012WO2012147674A1 Process for producing monatin
11/01/2012WO2012147556A1 Method for producing phosphite dehydrogenase protein and use thereof
11/01/2012WO2012146937A1 Lipase variants of ustilaginaceae
11/01/2012WO2012146935A1 Lipase variants having increased enzyme specificity or enhanced trans-selectivity, and methods of use
11/01/2012WO2012146597A1 High expression cereal phytase gene
11/01/2012WO2012146566A1 Method for improving pork
11/01/2012WO2012146564A1 Method for improving fresh meat
11/01/2012WO2012146260A1 Production and use of proteins in molecular biology
11/01/2012WO2012146171A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
11/01/2012WO2012120176A3 Recombinant proteins having antitumor effects
11/01/2012WO2012108672A9 Reverse transcriptase having improved thermostability
11/01/2012WO2012097318A3 Modified dna polymerases for improved amplification
11/01/2012WO2012088416A3 Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins
11/01/2012WO2011152568A8 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family, having attenuated expression of genes encoding a lysine/arginine/ornithine transporter
11/01/2012US20120278952 Polypeptides having Xylanase Activity and Polynucleotides Encoding Same
11/01/2012US20120278946 Isolation of proteins involved in posttranscriptional gene silencing and methods of use
11/01/2012US20120277451 Diacylglycerol acyltransferase genes and use thereof
11/01/2012US20120277285 Control of gene expression
11/01/2012US20120277254 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277236 Method for inhibiting mmp-9 dimerization
11/01/2012US20120277224 Heterocyclic compounds for the inhibition of pask
11/01/2012US20120277176 Protein Arginine Deiminase Inhibitors as Novel Therapeutics for Rheumatoid Arthritis and Cancer
11/01/2012US20120277161 Inhibition of multiple cell activation pathways
11/01/2012US20120277120 Methods for genomic modification
11/01/2012US20120276640 Polypeptides Having Cellobiohydrolase Activity And Polynucleotides Encoding Same
11/01/2012US20120276638 Methods of Improving the Introduction of DNA Into Bacterial Cells
11/01/2012US20120276611 Recombinantly modified plasmin
11/01/2012US20120276610 Isolation of A Protein Responsible For Uranium (VI) Reduction
11/01/2012US20120276609 Stabilization Of Perhydrolases
11/01/2012US20120276608 Multivalent Immunoglobulin-Based Bioactive Assemblies
11/01/2012US20120276600 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor
11/01/2012US20120276599 Ketoreductase polypeptides for the production of (r)-3-hydroxythiolane
11/01/2012US20120276595 Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials
11/01/2012US20120276594 Cellobiohydrolase variants
11/01/2012US20120276593 Use of cellulase and glucoamylase to improve ethanol yields from fermentation
11/01/2012US20120276589 Method for producing proteins comprising non-natural amino acids incorporated therein
11/01/2012US20120276586 Desmosterol-producing yeast strains and uses thereof
11/01/2012US20120276585 Method for producing fermentation products from lignocellulose-containing material
11/01/2012US20120276567 Talaromyces transformants
11/01/2012US20120276565 Stabilization of enzymes with stable coenzymes
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276247 Lipase Variants
11/01/2012US20120276145 Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
11/01/2012US20120276132 Atoxic recombinant holotoxins of Clostridium difficile as immunogens
11/01/2012US20120276131 Anti-trypanosomiasis vaccines and diagnostics
11/01/2012US20120276100 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/01/2012US20120276079 Method of producing recombinant vitamin k dependent proteins
11/01/2012US20120276078 Glycosidase enzymes
11/01/2012US20120276077 Therapeutic ribonucleases
11/01/2012US20120276075 Synergic action of a prolyl protease and tripeptidyl proteases
11/01/2012US20120276074 Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834633A1 Recombinant microorganisms for enhanced production of mevalonate, isoprene, and isoprenoids
11/01/2012CA2834626A1 Therapeutic nuclease compositions and methods